+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 5 Actively Recruiting clinical trials

I

Actively Recruiting

Researchers are conducting a Phase 3 clinical trial to evaluate the safety, tolerability, and efficacy of palopegteriparatide in adult participants with hypoparathyroidism. The study focuses on adults already receiving palopegteriparatide doses at or above 30 mcg per day. The trial aims to gather additional evidence on the treatment effects and safety profile of higher doses of this medication in this population. Participants will receive daily subcutaneous injections of palopegteriparatide, with doses individually adjusted using either a novel titration algorithm or a previously evaluated titration method. The treatment period lasts 78 weeks, during which participants will be randomly assigned to one of two groups receiving different dose titration strategies. Throughout the study, participants will undergo laboratory assessments to confirm eligibility and monitor health status, including measurements of serum calcium, vitamin D, magnesium, and kidney function. The primary outcome will be assessed at 26 weeks to evaluate treatment efficacy. Safety and tolerability will be continuously monitored during the 78-week treatment period. The trial is conducted in the United States and involves regular visits for dosing and assessments.

Age: 18Years +All GendersPhase 3
9 locations
R

Actively Recruiting

Researchers are evaluating treatment options for patients diagnosed with acute active clinically manifest cardiac sarcoidosis who have not yet received treatment. This phase 3 randomized controlled trial compares a low dose combination of Prednisone or Prednisolone and Methotrexate to standard dose Prednisone or Prednisolone. The study aims to assess whether the combination therapy is as effective as the standard dose while potentially offering better quality of life and fewer side effects. Participants will be randomly assigned to one of two groups. Outside Japan, one group receives Prednisone at 0.5 mgkgday for 6 months up to 30 mg daily, while the other gets Methotrexate once weekly starting at 15 mg, increasing to 20 mg if tolerated plus Folic Acid daily and Prednisone tapered over 3 months. In Japan, dosing regimens vary slightly but follow similar principles. Baseline tests include blood work, FDG-PET scans with myocardial perfusion imaging, ECG, echocardiogram, optional cardiac MRI, and quality of life questionnaires. Treatment lasts 6 months with scheduled visits at 4, 8 methotrexate group only, 12 weeks, and a final 6-month visit. During the study, participants undergo assessments for medication side effects, safety blood tests, and quality of life evaluations at multiple visits. At 6 months, comprehensive evaluations including imaging, biomarker analysis, device interrogation, muscle strength, skin and neuropsychiatric assessments will be completed. After this, further care is managed by the participants physician. The study measures heart function, medication effects, quality of life, and toxicity related to glucocorticoid use to understand the impact of these treatment strategies.

Age: 18Years +All GendersPhase 3
31 locations
S

Actively Recruiting

This research aims to evaluate the rates of cervical cancer screening and endometrial sampling before gender-affirming hysterectomy in transgender and gender diverse TGD individuals. The study seeks to assess the need for these tests in this population and explore patient-centered options to improve care. By linking screening status with hysterectomy pathology, it provides preliminary data on current guideline adherence and informs future evidence-based guidelines. The study is observational and does not involve an intervention. It compares standard cancer screening methods with options like HPV self-testing to see how these choices may influence screening rates and patient experiences. Participants include those who have had or plan to have a hysterectomy, focusing on capturing real-world screening practices. Participants will be observed over a 36-month period, during which researchers will measure screening and sampling rates and effects of HPV self-testing options. The study collects patient experience data and evaluates whether offering self-testing changes screening behavior. All assessments are observational without treatment administration, with follow-up continuing through the study duration.

Age: 18Years +All Genders
1 location
E

Actively Recruiting

Researchers are investigating a non-invasive way to assess elevated central venous pressure CVP in patients with heart failure HF. This study focuses on using Liver Stiffness Measurement LSM by FibroScan, which may offer a safer alternative to the current invasive catheter-based methods that carry risks and are not suitable for all patients. The study aims to evaluate the accuracy of LSM using a specific cutoff value to detect elevated CVP, which is an important marker of congestion in HF. Participants will undergo several assessments on the same day, including a FibroScan examination to measure liver stiffness, right-sided heart catheterization to directly measure CVP, echocardiography to assess heart function, and blood tests to check organ function. These procedures will be performed once at the start of the study to compare LSM results with invasive CVP measurements and other clinical markers. During the study, participants will be closely evaluated through imaging and laboratory tests to measure how well LSM identifies elevated CVP compared to the standard invasive method. Researchers will analyze correlations between LSM, echocardiographic parameters, blood biomarkers, and clinical factors. The main goal is to determine the sensitivity and specificity of LSM for diagnosing elevated CVP, with the entire assessment occurring on a single study day.

Age: 18Years +All GendersPhase Not Applicable
7 locations
S

Actively Recruiting

Scoliosis is a three-dimensional deformity that changes the spines shape and position. The most common type, adolescent idiopathic scoliosis AIS, affects mainly young adolescent females and can require bracing or surgery to prevent worsening. Researchers have developed a predictive model using 3D spinal measurements to better estimate curve progression in AIS. This study aims to refine and test this model in a larger group to help guide treatment decisions more accurately. The study uses a new low-dose biplanar X-ray system EOS to take stereo-radiographs and create 3D reconstructions of the spine and pelvis. These images help measure vertebrae, disks, and pelvic geometry in detail. Patients may receive usual treatments like bracing or surgery if needed, with bracing compliance monitored using special sensors. Surgical patients will have their data analyzed but leave the study after surgery. The goal is to validate the model by comparing the new 3D measurements with traditional methods over time. Participants will be followed for up to 24 months with visits ideally every 6 months, including physical exams, growth and maturity assessments, and X-rays without braces at least annually. The study collects detailed data at each visit to track scoliosis severity and curve changes using 3D spine reconstructions. Researchers will analyze these measurements to improve predictions of scoliosis progression and help identify which patients need early treatment to avoid surgery.

Age: 10Years - 15YearsAll Genders
9 locations